Kyrillos Sarigiannidis

Kyrillos Sarigiannidis currently serves as the Head of Drug Supply at Affimed since February 2023. Previously, Kyrillos held the position of Senior Manager Global Supply Chain at MorphoSys from April 2021 to September 2022, overseeing operational management for the IMP and compound lead for tafasitamab (Minjuvi). Prior experience includes working as an Investigational Medicinal Product Manager on the "Lightspeed" Project involving SARS-Cov-2 mRNA vaccines at BioNTech SE from January 2020 to March 2021. From January 2013 to December 2019, Kyrillos was a Project Lead/Study Manager in Clinical Supply Chain at CSL Behring GmbH. Earlier roles include Contractor for Supplies & Logistics with a major pharmaceutical sponsor, Senior Clinical Trials Coordinator as a freelancer, and various consultancy positions in clinical trials coordination. Kyrillos began a career in clinical research at ICON Clinical Research GmbH from 1998 to 2011. Educational background includes a degree from Technische Universität Darmstadt, completed between 1989 and 1997.